US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist
  • 1.800
  • -0.060-3.23%
Close Dec 27 16:00 ET
  • 1.810
  • +0.010+0.56%
Post 19:55 ET
83.84MMarket Cap-1.67P/E (TTM)

About Reviva Pharmaceuticals Company

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.

Company Profile

SymbolRVPH
Company NameReviva Pharmaceuticals
Listing DateOct 18, 2018
Founded2020
CEODr. Laxminarayan Bhat, PhD
MarketNASDAQ
Employees15
Fiscal Year Ends12-31
Address10080 North Wolfe Road,Suite SW3-200
CityCupertino
ProvinceCalifornia
CountryUnited States of America
Zip Code95014
Phone1-408-501-8881
Websitehttp://www.revivapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Laxminarayan Bhat, PhD
  • Director, President and Chief Executive Officer
  • 2.76M
  • Narayan Prabhu
  • Chief Financial Officer and Principal Accounting Officer
  • 1.25M
  • Parag Saxena
  • Chairman of the Board
  • 107.01K
  • Dr. Richard Margolin, M.D.
  • Independent Director
  • 81.76K
  • Purav Patel
  • Independent Director
  • 90.51K
  • Les Funtleyder
  • Independent Director
  • 88.01K
Heat List
US
Overall
Symbol
Price
% Chg

No Data